Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters-Reference-Cited by-同舟云学术

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters

Published:2013-11 Issue:11 Volume:8 Page:1396-1401
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Cuaron John J.,Yorke Ellen D.,Foster Amanda,Hsu Meier,Zhang Zhigang,Liu Fan,Jackson Andrew,Mychalczak Borys,Rosenzweig Kenneth E.,Wu Abraham J.,Rimner Andreas

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication;Dosoretz;Int J Radiat Oncol Biol Phys,1993

2. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience;Sibley;Int J Radiat Oncol Biol Phys,1998

3. Radiation therapy alone for stage I non-small cell lung cancer;Kaskowitz;Int J Radiat Oncol Biol Phys,1993

4. Radical radiotherapy of inoperable non-small cell lung cancer. Irradiation techniques and tumor characteristics in relation to local control and survival;Wigren;Acta Oncol,1992

5. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer – A Phase I Dose Escalation Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

2. Stereotactic body radiation therapy for sarcoma pulmonary metastases;Radiotherapy and Oncology;2023-10

3. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases;Radiation Oncology Journal;2021-12-31

4. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?;International Journal of Radiation Oncology*Biology*Physics;2021-05

5. Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer;Nature Reviews Clinical Oncology;2021-04-28